Urinalysis helps in the diagnosis of renal and urinary tract abnormalities and various other diseases. The process involves macroscopic examination, chemical analysis, and microscopic urine sediment examination. Urine sediment analyzers interface with automated strip analyzers to produce comprehensive routine urinalysis reports. A new report from Markets and Markets estimates that the global urinalysis market will reach $1.28 billion by 2019 from $0.89 billion in 2014, growing at a CAGR of 7.6% from 2014 to 2019.
Based on test type, the sediment urinalysis segment is expected to grow at the highest CAGR from 2014 to 2019. End users of this automated systems are- Hospitals and Clinics, Research Laboratories, Diagnostic Laboratories and Home Care Setting. Major factors driving the growth of the market include:
- Increased insurance coverage with implementation of the Affordable Care Act (ACA)
- Aging population
- Technological advancements
- Launch of new products
The report also lists factors that could hamper the growth of the market — varied regulatory stringency across globe which delays the product launch and low adoption rate of fully automated urinalysis systems in less developed countries.
The leading players in the market are- Alere Inc. (Acon Labs) (U.S.), ARKRAY Inc. (Japan), Bio-Rad (U.S.), Danaher (Iris International) (U.S.), E77 Eletronika (Hunagary), Mindray (China), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Sysmex (Japan), and Urit Medical (China). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).